about
Transgenic expression of cyclooxygenase-2 (COX2) causes premature aging phenotypes in mice.Downregulation of telomerase activity by diclofenac and curcumin is associated with cell cycle arrest and induction of apoptosis in colon cancer.Lentivirus-mediated somatic recombination and development of a novel mouse model for sporadic colorectal cancer.The role of NF-κB and PPARγ in experimentally induced colorectal cancer and chemoprevention by cyclooxygenase-2 inhibitors.Chemopreventive role of etoricoxib (MK-0663) in experimental colon cancer: induction of mitochondrial proapoptotic factors.Angiostatic properties of sulindac and celecoxib in the experimentally induced inflammatory colorectal cancer.Role of cytokines and Jak3/Stat3 signaling in the 1,2-dimethylhydrazine dihydrochloride-induced rat model of colon carcinogenesis: early target in the anticancer strategy.Downregulation of PI3-K/Akt/PTEN pathway and activation of mitochondrial intrinsic apoptosis by Diclofenac and Curcumin in colon cancer.Dolastatin, along with Celecoxib, stimulates apoptosis by a mechanism involving oxidative stress, membrane potential change and PI3-K/AKT pathway down regulation.Sulindac and Celecoxib regulate cell cycle progression by p53/p21 up regulation to induce apoptosis during initial stages of experimental colorectal cancer.Role of cytokines in experimentally induced lung cancer and chemoprevention by COX-2 selective inhibitor, etoricoxib.Chemopreventive effects of NSAIDs as inhibitors of cyclooxygenase-2 and inducers of apoptosis in experimental lung carcinogenesis.Role of Sulindac and Celecoxib in the regulation of angiogenesis during the early neoplasm of colon: exploring PI3-K/PTEN/Akt pathway to the canonical Wnt/β-catenin signaling.The Role of IL-33/ST2 Pathway in TumorigenesisRole of Sulindac and Celecoxib in chemoprevention of colorectal cancer via intrinsic pathway of apoptosis: exploring NHE-1, intracellular calcium homeostasis and Calpain 9Dolastatin 15, a mollusk linear peptide, and Celecoxib, a selective cyclooxygenase-2 inhibitor, prevent preneoplastic colonic lesions and induce apoptosis through inhibition of the regulatory transcription factor NF-κB and an inflammatory protein, iUp-regulation of p53 and mitochondrial signaling pathway in apoptosis by a combination of COX-2 inhibitor, Celecoxib and Dolastatin 15, a marine mollusk linear peptide in experimental colon carcinogenesisAngiostatic role of the selective cyclooxygenase-2 inhibitor etoricoxib (MK0663) in experimental lung cancerChemopreventive effects of non-steroidal anti-inflammatory drugs in early neoplasm of experimental colorectal cancer: an apoptosome studyImatinib modulates pro-inflammatory microenvironment with angiostatic effects in experimental lung carcinogenesis
P50
Q37423527-96DC7EF5-0D9E-4AE5-813E-504BC7DD2150Q38903062-245CD84F-186C-495D-B7C2-7F4923B13323Q40821808-2B43E3BE-8CCF-455B-AF16-4A77995021B8Q43049437-25A88141-895A-453E-95D7-1F57E393398DQ43075231-3B8560C0-CA14-4D53-9594-2AB03441DE3CQ43601028-3C511549-7DEA-421F-85C0-D597C84A5412Q43829850-F1D69B63-6B6B-4B9D-8665-FAF1CDA5E334Q46778603-DD61E820-D742-40E2-BC3C-4D8F6D9061DEQ47970861-B37F2E55-326A-4E74-8217-749DCA24F44AQ48001444-64BCC032-CF7D-41B0-9696-E7B466C64AF7Q49080440-292CE18C-33B6-406A-A013-7CCB69D4031DQ53272908-8344BFD5-1B1A-4232-AB4C-9EE24BCD386EQ54524896-E99233EF-3AC0-4D6E-9EC9-A0195D0FC7C6Q58756972-33BACE0A-A1B1-4C96-A719-CCDF22B7B281Q83573804-75BC3C71-F5EC-4800-BBDD-8359C3388EACQ83731161-62F4FCEC-287F-41C5-916E-613EEFA43D83Q84205712-4774F38A-0B76-4E5E-AA6F-1E9261B0BCD8Q84340054-69D622E0-B8DB-4A92-A5DA-845CB425658EQ84561730-5125ECAC-5D7D-46C9-8A2A-58E084D3C334Q91063517-BCB76238-D27E-4812-A259-5BFB74FE1D6B
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Vivek Vaish
@en
Vivek Vaish
@nl
type
label
Vivek Vaish
@en
Vivek Vaish
@nl
prefLabel
Vivek Vaish
@en
Vivek Vaish
@nl
P31
P496
0000-0003-4491-3832